Mitoxantrone
Showing 26 - 50 of 438
Acute Myeloid Leukemia Trial in Pittsburgh (mitoxantrone + etoposide + gemtuzumab ozogamicin)
Recruiting
- Acute Myeloid Leukemia
- mitoxantrone + etoposide + gemtuzumab ozogamicin
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Feb 9, 2022
Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Cyclophosphamide)
Not yet recruiting
- Diffuse Large B-cell Lymphoma
- Rituximab
- +4 more
- (no location specified)
Mar 9, 2023
Advanced Pancreatic Cancer Trial (Mitoxantrone Hydrochloride Liposome injection)
Not yet recruiting
- Advanced Pancreatic Cancer
- Mitoxantrone Hydrochloride Liposome injection
- (no location specified)
Oct 19, 2021
Advanced Malignant Tumor Trial (Mitoxantrone Hydrochloride Liposome)
Not yet recruiting
- Advanced Malignant Tumor
- Mitoxantrone Hydrochloride Liposome
- (no location specified)
Oct 9, 2021
Relapsed Adult AML Trial in Germany (Venetoclax Oral Tablet)
Recruiting
- Relapsed Adult AML
- Refractory AML
- Venetoclax Oral Tablet
-
Augsburg, Germany
- +11 more
Jan 11, 2023
Relapsed/Refractory Acute Myeloid Leukemia Trial in Worldwide (CPI-613 + High Dose Cytarabine and Mitoxantrone, High Dose
Terminated
- Relapsed/Refractory Acute Myeloid Leukemia
- CPI-613 + High Dose Cytarabine and Mitoxantrone
- +3 more
-
Scottsdale, Arizona
- +59 more
Jul 26, 2022
Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Isophosphamide)
Not yet recruiting
- Diffuse Large B-cell Lymphoma
- Rituximab
- +7 more
- (no location specified)
Mar 23, 2023
Peripheral T-cell Lymphoma Trial in Tianjin (Lposomal mitoxantrone HCl,Cyclophosphamide,Vincristine,Etoposide and
Not yet recruiting
- Peripheral T-cell Lymphoma
- Lposomal mitoxantrone hydrochloride,Cyclophosphamide,Vincristine,Etoposide and Prednisone(CMOEP)
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Insititute & Hospital
Jul 13, 2022
Lymphoma, Autologous Hematopoietic Stem Cell Transplantation Trial in Xi'an (Improved BEAM regimen)
Not yet recruiting
- Lymphoma
- Autologous Hematopoietic Stem Cell Transplantation
- Improved BEAM regimen
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Dec 26, 2022
Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML) Trial in Guiyang (Mitoxantrone Hydrochloride liposome
Not yet recruiting
- Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Mitoxantrone Hydrochloride liposome injection
- Cytarabine (LoDAC)
-
Guiyang, Guizhou, ChinaThe Affiliated Hospital of Guizhou Medical University
Oct 19, 2021
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- Clofarabine
- Mitoxantrone
-
Valhalla, New York
- +1 more
Oct 29, 2021
Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen
Not yet recruiting
- Leukemia, Myeloid, Acute
- AML Stage, Adult
- Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
-
Xiamen, Fujian, ChinaBing Xu
Oct 29, 2022
DLBCL Trial in Suzhou (Chidamide, Azacitidine, obinutuzumab)
Recruiting
- Diffuse Large B-Cell Lymphoma
- Chidamide
- +3 more
-
Suzhou, Jiangsu, Chinathe First Affiliated Hospital of Soochow University
Apr 10, 2023
Treatment-naïve, Peripheral T Cell Lymphoma Trial in Guangzhou (Dose-finding stage: Liposomal mitoxantrone HCl,
Recruiting
- Treatment-naïve
- Peripheral T Cell Lymphoma
- Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
- Dose-expansion stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 26, 2021
Lymphoblastic Leukemia Trial in Palo Alto (Dexamethasone, Mitoxantrone, PEG asparaginase)
Not yet recruiting
- Lymphoblastic Leukemia
- Dexamethasone
- +8 more
-
Palo Alto, CaliforniaStanford University
Apr 27, 2023
Advanced Solid Tumor Trial in China (Mitoxantrone Hydrochloride Liposome, intravenous injection (IV))
Active, not recruiting
- Advanced Solid Tumor
- Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
-
Bengbu, Anhui, China
- +7 more
Oct 28, 2021
Advanced Solid Tumors Trial in Baoding (Mitoxantrone Hydrochloride Liposome injection)
Not yet recruiting
- Advanced Solid Tumors
- Mitoxantrone Hydrochloride Liposome injection
-
Baoding, Hebei, ChinaAffiliated Hospital of Hebei University
Jun 4, 2021
T-cell-prolymphocytic Leukemia Trial in Cologne (Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab, Alemtuzumab)
Completed
- T-cell-prolymphocytic Leukemia
- Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab
- Alemtuzumab
-
Cologne, GermanyUniversity Hospital Cologne
Dec 16, 2021
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)
Completed
- Acute Leukemia of Ambiguous Lineage
- +2 more
- Cladribine
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 23, 2022
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,
Recruiting
- Acute Biphenotypic Leukemia
- +11 more
- Cladribine
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 18, 2022
Unresectable or Metastatic Bone and Soft Tissue Sarcoma Trial (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Unresectable or Metastatic Bone and Soft Tissue Sarcoma
- Mitoxantrone Hydrochloride Liposome Injection
- (no location specified)
May 20, 2021
Recurrent Head Neck Cancer, Metastatic Head Neck Cancer Trial (Mitoxantrone Hydrochloride Liposome, intravenous injection (IV))
Not yet recruiting
- Recurrent Head and Neck Cancer
- Metastatic Head and Neck Cancer
- Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
- (no location specified)
May 20, 2021
Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Venetoclax
- +9 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 21, 2023